BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 31677073)

  • 1. Carbamazepine promotes specific stimuli-induced NLRP3 inflammasome activation and causes idiosyncratic liver injury in mice.
    Wang Z; Xu G; Zhan X; Liu Y; Gao Y; Chen N; Guo Y; Li R; He T; Song X; Niu M; Wang J; Bai Z; Xiao X
    Arch Toxicol; 2019 Dec; 93(12):3585-3599. PubMed ID: 31677073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icariside I specifically facilitates ATP or nigericin-induced NLRP3 inflammasome activation and causes idiosyncratic hepatotoxicity.
    Gao Y; Xu G; Ma L; Shi W; Wang Z; Zhan X; Qin N; He T; Guo Y; Niu M; Wang J; Bai Z; Xiao X
    Cell Commun Signal; 2021 Feb; 19(1):13. PubMed ID: 33573688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bavachin enhances NLRP3 inflammasome activation induced by ATP or nigericin and causes idiosyncratic hepatotoxicity.
    Qin N; Xu G; Wang Y; Zhan X; Gao Y; Wang Z; Fu S; Shi W; Hou X; Wang C; Li R; Liu Y; Wang J; Zhao H; Xiao X; Bai Z
    Front Med; 2021 Aug; 15(4):594-607. PubMed ID: 33909257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoxanthohumol, a component of Sophora flavescens, promotes the activation of the NLRP3 inflammasome and induces idiosyncratic hepatotoxicity.
    Lin L; Chen Y; Li Q; Xu G; Ding K; Ren L; Shi W; Wang Y; Li Z; Dai W; Wei Z; Yang Y; Bai Z; Xiao X
    J Ethnopharmacol; 2022 Mar; 285():114796. PubMed ID: 34740771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoralidin, a major component of Psoraleae Fructus, induces inflammasome activation and idiosyncratic liver injury.
    Wang Y; Xu G; Wang Z; Li R; Zhan X; Liu H; Qin Q; Li W; Wang X; Zhang M; Tang J; Bai Z; Xiao X
    Int Immunopharmacol; 2021 Mar; 92():107352. PubMed ID: 33422760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isomaculosidine facilitates NLRP3 inflammasome activation by promoting mitochondrial reactive oxygen species production and causes idiosyncratic liver injury.
    Shi W; Liu T; Yang H; Zhao J; Wei Z; Huang Y; Li Z; Li H; Liang L; Hou X; Chen Y; Gao Y; Bai Z; Xiao X
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117063. PubMed ID: 37598766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icariside Ⅱ, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activation.
    Wang Z; Xu G; Wang H; Zhan X; Gao Y; Chen N; Li R; Song X; Guo Y; Yang R; Niu M; Wang J; Liu Y; Xiao X; Bai Z
    Acta Pharm Sin B; 2020 Sep; 10(9):1619-1633. PubMed ID: 33088683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
    Gong Z; Zhou J; Zhao S; Tian C; Wang P; Xu C; Chen Y; Cai W; Wu J
    Oncotarget; 2016 Dec; 7(51):83951-83963. PubMed ID: 27924062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production.
    Hu Y; Mao K; Zeng Y; Chen S; Tao Z; Yang C; Sun S; Wu X; Meng G; Sun B
    J Immunol; 2010 Dec; 185(12):7699-705. PubMed ID: 21048113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of sphingosine-1-phosphate receptor 3 suppresses ATP-induced NLRP3 inflammasome activation in macrophages
    Wang Y; Wang C; He Q; Chen G; Yu J; Cang J; Zhong M
    Front Immunol; 2023; 14():1090202. PubMed ID: 36798132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baeckein E suppressed NLRP3 inflammasome activation through inhibiting both the priming and assembly procedure: Implications for gout therapy.
    Lin X; Wang H; An X; Zhang J; Kuang J; Hou J; Yan M
    Phytomedicine; 2021 Apr; 84():153521. PubMed ID: 33667838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol ameliorates Propionibacterium acnes/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3.
    Yan CY; Ouyang SH; Wang X; Wu YP; Sun WY; Duan WJ; Liang L; Luo X; Kurihara H; Li YF; He RR
    Phytomedicine; 2021 Jan; 80():153398. PubMed ID: 33130474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic Agent Paclitaxel Mediates Priming of NLRP3 Inflammasome Activation.
    Son S; Shim DW; Hwang I; Park JH; Yu JW
    Front Immunol; 2019; 10():1108. PubMed ID: 31156650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1'-Acetoxychavicol acetate inhibits NLRP3-dependent inflammasome activation via mitochondrial ROS suppression.
    Sok SPM; Ori D; Wada A; Okude H; Kawasaki T; Momota M; Nagoor NH; Kawai T
    Int Immunol; 2021 Jun; 33(7):373-386. PubMed ID: 33830232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forskolin attenuates the NLRP3 inflammasome activation and IL-1β secretion in human macrophages.
    Chen Y; Wen JG; Feng JJ; Wang YH; Li TF; Nurmi K; Eklund KK; Xing D
    Pediatr Res; 2019 Dec; 86(6):692-698. PubMed ID: 31086288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NLRP3 Inflammasome Activation and Pyroptosis in Macrophages by Taraxasterol Is Associated With Its Regulation on mTOR Signaling.
    Yang F; Ye XJ; Chen MY; Li HC; Wang YF; Zhong MY; Zhong CS; Zeng B; Xu LH; He XH; Ouyang DY
    Front Immunol; 2021; 12():632606. PubMed ID: 33679781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
    Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epoxyeicosatrienoic acids inhibit the activation of NLRP3 inflammasome in murine macrophages.
    Luo XQ; Duan JX; Yang HH; Zhang CY; Sun CC; Guan XX; Xiong JB; Zu C; Tao JH; Zhou Y; Guan CX
    J Cell Physiol; 2020 Dec; 235(12):9910-9921. PubMed ID: 32452554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel Enhances the Innate Immunity by Promoting NLRP3 Inflammasome Activation in Macrophages.
    Zeng QZ; Yang F; Li CG; Xu LH; He XH; Mai FY; Zeng CY; Zhang CC; Zha QB; Ouyang DY
    Front Immunol; 2019; 10():72. PubMed ID: 30761140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
    Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
    J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.